Literature DB >> 14336525

EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.

E HANSSON, R M FLEMING, W G CLARK.   

Abstract

Entities:  

Keywords:  AMINES; CARBON ISOTOPES; CARBOXY-LYASES; DOPA; EXPERIMENTAL LAB STUDY; HYDRAZINES; HYDROXYTRYPTOPHAN; IPRONIAZID; METABOLISM; MICE; PHARMACOLOGY; RADIOMETRY; SEROTONIN; TREMOR

Mesh：

Substances：

Year:  1964        PMID： 14336525     DOI： 10.1016/0028-3908(64)90006-1

Source DB:  PubMed          Journal:  Int J Neuropharmacol        ISSN： 0375-9458


× No keyword cloud information.
  5 in total

1.  Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.

Authors:  B K Koe
Journal:  Experientia       Date:  1975-06-15

2.  Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.

Authors:  P M Howse; W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-02       Impact factor: 10.154

3.  Inhibition of tyrosine degradation in vivo by the dopa decarboxylase blocking agent NSD-1034.

Authors:  K Hempel; H F Männl
Journal:  Experientia       Date:  1968-05-15

4.  NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.

Authors:  H Nissbrandt; G Engberg; H Wikström; T Magnusson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

5.  A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.

Authors:  J W Commissiong; E M Sedgwick
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.